Skip to content
    BB

    BlueCross BlueShield Venture Partners

    BlueCross BlueShield Venture Partners is a seed to Series E stage investment firm. It has made 9 investments. 40% of their portfolio is in Healthcare. Average disclosed round size is $56.9M (across 10 rounds with reported amounts).

    Find people at BlueCross BlueShield Venture Partners on Goldilocks AI

    Portfolio

    9

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    0

    Team

    AH

    Anna Haghgooie

    Managing Director

    DT

    Dipa Talati Mehta

    Managing Director

    PB

    Paul Brown

    Managing Director

    KG

    Kyle Gay

    Healthcare Investor

    Portfolio Breakdown

    Stage Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    10 investments
    CompanyRoundAmountDate
    SSoleraSeries E$40MJan 2025
    Somatus logoSomatusSeries E$325MFeb 2022
    LLumiataSeries B$14MJan 2021
    Physera logoPhyseraSeries A$8MJan 2019
    TThrive Earlier DetectionSeries A$110MJan 2019
    LLumiataUnknown$11MJan 2018
    IId ExpertsUnknown$27.5MAug 2016
    PPhreesia, Inc.Series D$20M—
    SonarMD logoSonarMDSeries A$10M—
    Allay logoAllaySeed$3.4M—

    Top Co-Investors

    Sandbox Industries6 shared
    Allegis2 shared
    Khosla Ventures2 shared
    The Blue Venture Fund2 shared
    HLM Investment Partners1 shared
    Village Global1 shared
    Polaris Partners1 shared
    HLM Venture Partners1 shared
    Intel Capital1 shared
    Innovation Endeavors1 shared
    Slow Ventures1 shared
    Lux Capital1 shared
    Expa1 shared
    Casdin Capital1 shared
    Section 321 shared
    Third Rock Ventures1 shared
    Perceptive Advisors1 shared
    Biomatics Capital1 shared
    The Invus Group, LLC1 shared
    Longitude Capital1 shared

    Last updated: 19 September 2026